Metabolic & Atherosclerosis Research Center (MARC) — Cincinnati, Ohio

Public research footprint of Metabolic & Atherosclerosis Research Center (MARC), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Most-studied conditions

Hypercholesterolemia · Cardiovascular Diseases · Migraine With Aura · Cardiovascular Disease With Mention of Arteriosclerosis

Recently updated registry entries

NCT07102511 — Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With… (Enrolling By Invitation)
NCT04798430 — Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients… (Enrolling By Invitation)
NCT04806893 — Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients… (Unknown)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Metabolic & Atherosclerosis Research Center (MARC)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.